Literature DB >> 34152095

Telomere shortening in late-life depression: A potential marker of depression severity.

Ana Paula Mendes-Silva1, Erica Leandro Marciano Vieira1, Gabriela Xavier2,3, Lucelia Scarabeli Silva Barroso4, Laiss Bertola4, Efrem Augusto Ribeiro Martins4, Elisa Macedo Brietzke5,6, Sintia Iole Nogueira Belangero2,3, Breno Satler Diniz1,7,8,9.   

Abstract

OBJECTIVES: Telomeres are structures at the extremity of chromosomes that prevents genomic instability, and its shortening seems to be a hallmark of cellular aging. Past studies have shown contradictory results of telomere length (TL) in major depression, and are a few studies in late-life depression (LLD). This explores the association between TL as a molecular marker of aging and diagnosis of LLD, the severity of depressive symptoms, and cognitive performance in older adults. METHODS/
DESIGN: We included 78 older adults (45 with LLD and 33 nondepressed controls, according to DSM-V criteria), aged 60-90 years. TL was measured in leukocytes by a quantitative polymerase chain reaction, determining the relative ratio (T/S) between the telomere region copy number (T) and a single copy gene (S), using a relative standard curve.
RESULTS: TL was significantly shorter in the LLD compared with control participants (p = .039). Comparing groups through the severity of depressive symptoms, we found a negative correlation with the severity of depressive symptoms (Hamilton Depression Rating Scale-21, r = -0.325, p = .004) and medical burden (r = -0.271, p = .038). There was no significant correlation between TL and cognitive performance (Mattis Dementia Rating Scale, r = 0.152, p = .21).
CONCLUSIONS: We found that older adults with LLD have shorter telomere than healthy controls, especially those with a more severe depressive episode. Our findings suggest that shorter TL can be a marker of the severity of depressive episodes in older adults and indicate that these individuals may be at higher risk of age-associated adverse outcomes linked to depression.
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Entities:  

Keywords:  aging; cellular senescence; late-life depression; telomere length

Year:  2021        PMID: 34152095     DOI: 10.1002/brb3.2255

Source DB:  PubMed          Journal:  Brain Behav            Impact factor:   2.708


  4 in total

1.  Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs.

Authors:  Mélusine Durand; Nicolas Nagot; Laurent Michel; Sao Mai Le; Huong Thi Duong; Roselyne Vallo; Amélie Vizeneux; Delphine Rapoud; Hoang Thi Giang; Catherine Quillet; Nham Thi Tuyet Thanh; Khuat Thi Hai Oanh; Vu Hai Vinh; Jonathan Feelemyer; Philippe Vande Perre; Khue Pham Minh; Didier Laureillard; Don Des Jarlais; Jean-Pierre Molès
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

2.  Altered Intrinsic Brain Activity in Patients With Late-Life Depression: A Resting-State Functional MRI Study.

Authors:  Chaomeng Liu; Weigang Pan; Dandi Zhu; Peixian Mao; Yanping Ren; Xin Ma
Journal:  Front Psychiatry       Date:  2022-05-23       Impact factor: 5.435

Review 3.  Telomere Shortening and Its Association with Cell Dysfunction in Lung Diseases.

Authors:  Andy Ruiz; Julio Flores-Gonzalez; Ivette Buendia-Roldan; Leslie Chavez-Galan
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

4.  Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome.

Authors:  Breno S Diniz; Benoit H Mulsant; Charles F Reynolds; Daniel M Blumberger; Jordan F Karp; Meryl A Butters; Ana Paula Mendes-Silva; Erica L Vieira; George Tseng; Eric J Lenze
Journal:  JAMA Netw Open       Date:  2022-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.